Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INFORMUS: Cardiovascular Outcomes Trial of Naltrexone/Bupropion in Obesity
NCT06098079Phase 4Active, not recruiting
- Sponsor
- Currax Pharmaceuticals LLC
- Start
- Jan 2024
- Primary completion
- Jan 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of naltrexone, bupropion in obesity, sponsored by Currax Pharmaceuticals LLC. Started Jan 2024; status: active, not recruiting.
02
Drugs
naltrexonebupropion
03
Conditions
obesity
Beyond the preview
Go deeper on NCT06098079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06098079.